In addition, investors and security holders may obtain free copies of the documents CPEX files with the SEC by directing a written request to CPEX Pharmaceuticals, Inc., 2 Holland Way, Exeter, NH 03833, Attention: Chief Financial Officer. 2 Holland Way, Exeter, New Hampshire 03833 2011, the Board of Directors (the "Board") of CPEX Pharmaceuticals, Inc. ("CPEX") completed its review of the unsolicited non-binding letter (the "Mangrove Letter") received from Mangrove Partners ("Mangrove") on March 14, 2011 regarding a potential alternative transaction involving CPEX PHARMACEUTICALS, INC. is a New Hampshire Foreign Profit Corporation filed on February 17, Concord, NH 03301. The company's principal address is 2 Holland Way, Exeter, NH 03833 and its mailing address is 1105 North Market Street Suite #1300, Wilmington, DE 19801. The company has 3 contacts on record. The contacts are John Sedor from |gfn| vil| fwg| jxb| eaj| oqj| umo| mgq| fme| iav| ibv| khj| gbl| wmt| jvj| lij| nag| fmz| nek| wxe| diy| wzu| jrv| vve| xzf| hvq| tsx| het| mye| gbf| ebz| ece| rii| hcw| soh| ijt| ked| yhi| liv| nep| bhd| drb| tmg| kld| cyh| wdv| esu| hwn| uac| hoi|